Search Results - "Diap, Graciela"
-
1
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Published in The lancet. Gastroenterology & hepatology (01-02-2019)“…Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major…”
Get more information
Journal Article -
2
Delivering two new treatments for malaria: a story of inventive partnerships
Published in Malaria journal (15-10-2012)“…Doc number: P57…”
Get full text
Journal Article -
3
Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone
Published in PloS one (25-10-2012)“…Malaria remains the leading burden of disease in post-conflict Sierra Leone. To overcome the challenge of anti-malarial drug resistance and improve effective…”
Get full text
Journal Article -
4
Anti-malarial market and policy surveys in sub-Saharan Africa
Published in Malaria journal (23-04-2010)“…At a recent meeting (Sept 18, 2009) in which reasons for the limited access to artemisinin-based combination therapy (ACT) in sub-Saharan Africa were…”
Get full text
Journal Article -
5
Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
Published in Malaria journal (10-02-2011)“…Malaria is the leading cause of morbidity and mortality in post-conflict Burundi. To counter the increasing challenge of anti-malarial drug resistance and…”
Get full text
Journal Article -
6
-
7
Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data
Published in The Lancet (British edition) (01-12-2012)“…Summary Background Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those…”
Get full text
Journal Article -
8
New, improved treatments for Chagas disease: from the R&D pipeline to the patients
Published in PLoS neglected tropical diseases (01-07-2009)Get full text
Journal Article -
9
The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study
Published in Malaria journal (21-02-2013)“…The Drugs for Neglected Diseases initiative (DNDi) is a not-for profit organization committed to providing affordable medicines and access to treatments in…”
Get full text
Journal Article -
10
Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross‐sectional retail surveys
Published in Tropical medicine & international health (01-06-2015)“…Objectives To describe the state of the public and private malaria diagnostics market shortly after WHO updated its guidelines for testing all suspected…”
Get full text
Journal Article -
11
Improving access to malaria medicine through private-sector subsidies in seven African countries
Published in Health Affairs (01-09-2014)“…Improving access to quality-assured artemisinin combination therapies (ACTs) is an important component of malaria control in low- and middle-income countries…”
Get full text
Journal Article -
12
The affordable medicines facility - malaria in Ghana: baseline and endline survey findings
Published in Malaria journal (15-10-2012)“…Doc number: P109…”
Get full text
Journal Article -
13
Access to Artemisinin-Combination Therapy
Published in PloS one (25-10-2012)“…Malaria remains the leading burden of disease in post-conflict Sierra Leone. To overcome the challenge of anti-malarial drug resistance and improve effective…”
Get full text
Journal Article -
14
Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention
Published in Malaria journal (04-02-2014)“…The Affordable Medicines Facility - malaria (AMFm), implemented at national scale in eight African countries or territories, subsidized quality-assured…”
Get full text
Journal Article -
15
Effect of the Affordable Medicines Facilityamalaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data
Published in The Lancet (British edition) (07-12-2012)“…Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those in need, and there…”
Get full text
Journal Article -
16
New, improved treatments for Chagas disease: from the R D pipeline to the patients
Published in PLoS neglected tropical diseases (01-01-2009)Get full text
Journal Article